Simpson MA, Weigel JA, Weigel PH. (2012) Systemic blockade of the hyaluronan receptor for endocytosis (HARE) prevents lymph node metastasis of prostate cancer. Int J Cancer. 2012 Jan 10. doi: 10.1002/ijc.27427. [Epub ahead of print]

Hlady RA, Novakova S, Opavska J, Klinkebiel D, Peters SL, Bies J, Hannah J, Iqbal J, Anderson KM, Siebler HM, Smith LM, Greiner TC, Bastola D, Joshi S, Lockridge O, Simpson MA, Felsher DW, Wagner KU, Chan WC, Christman JK, Opavsky R. (2012) Loss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesis. J Clin Invest. 2012 Jan 3;122(1):163-77. doi: 10.1172/JCI57292. Epub 2011 Dec 1.

Willis MN, Liu Y, Biterova EI, Simpson MA, Kim H, Lee J, Barycki JJ. (2011) Enzymatic Defects Underlying Hereditary Glutamate Cysteine Ligase Deficiency Are Mitigated by Association of the Catalytic and Regulatory Subunits.  Biochemistry.  Jul 26;50(29):6508-17. Epub 2011 Jun 29.

Kovar JL, Xu X, Draney D, Cupp A, Simpson MA, Michael Olive D. (2011) Near-infrared-labeled tetracycline derivative is an effective marker of bone deposition in mice.  Anal Biochem. Sep 15;416(2):167-73. Epub 2011 May 12.

Bharadwaj AG, Goodrich NP, McAtee CO, Haferbier K, Oakley GG, Wahl III JK, and Simpson MA. (2011) Hyaluronan suppresses prostate tumor cell proliferation through diminished expression of N-cadherin and aberrant growth factor receptor signaling. Exp Cell Res. 317(8): 1214-1225.

Huang D, Casale G, Tian J, Lele SM, Pisarev VM, Simpson MA and Hemstreet III GP. (2010) UDP-glucose dehydrogenase as a novel field-specific candidate biomarker of prostate cancer. Int J Cancer 126(2): 315-327.

Simpson MA. Hyaluronan synthesis and turnover in prostate cancer. (2009) Chapter 16 in Hyaluronan in Cancer Biology, pp. 309-327. Ed. Robert Stern, Oxford: Academic Press.

Zhang L, Bharadwaj AG, Casper A, Barkley J, Barycki JJ and Simpson MA. (2009) Hyaluronidase activity of human Hyal1 requires active site acidic and tyrosine residues. J Biol Chem 284: 9433-9442.

Wei Q, Galbenus R, Raza A, Cerny RL and Simpson MA. (2009) Androgen-stimulated UDP-glucose dehydrogenase expression limits prostate androgen availability without impacting hyaluronan levels. Cancer Research 69(6): 2332-2339.

Bharadwaj AG, Kovar JL, Loughman E, Elowsky C, Oakley GG and Simpson MA. (2009) Spontaneous metastasis of prostate cancer is promoted by excess hyaluronan synthesis and processing. Amer J Pathol. 174(3): 1027-1036.

Kovar JL, Ke S, Volcheck WM, Sevick-Muraca E, Simpson MA and Olive DM. (2009) Characterization and performance of a near infrared 2-deoxyglucose optical imaging agent for mouse cancer models. Anal Biochem, 384(2):254-62.

Simpson MA and Lokeshwar VB. (2008) Hyaluronan and hyaluronidase in genitourinary tumors. Invited Review. Frontiers in Bioscience 13: 5664-80.

Bharadwaj AG, Rector K, Simpson MA. (2007) Inducible hyaluronan production reveals differential effects on prostate tumor cell growth and tumor angiogenesis. J Biol Chem. 282(28): 20561-72.

Kovar JL, Simpson MA, Geschwender A and Olive DM. (2007) A systematic approach to the development of fluorescent contrast agents for optical imaging of mouse cancer models. Review. Anal Biochem. 367(1): 1-12.

Kovar JL, Volcheck WM, Chen J and Simpson MA. (2007) Purification method directly influences effectiveness of an epidermal growth factor-coupled targeting agent for noninvasive tumor detection in mice. Anal Biochem. 361(1): 47-54.

Easley KE, Sommer BJ, Boanca G, Barycki JJ, and Simpson MA. (2007) Characterization of human UDP-glucose dehydrogenase reveals critical catalytic roles for lysine 220 and aspartate 280. Biochemistry 46(2): 369-78.

Kovar JL, Johnson MA, Volcheck WM, Chen J and Simpson MA. (2006) Hyaluronidase induces prostate tumor metastasis in an orthotopic mouse model. Amer J Pathol. 169(4): 1415-26.

Simpson MA. (2006) Concurrent expression of hyaluronan biosynthesis and processing enzymes promotes growth and vascularization of prostate tumors in mice. Amer J Pathol. 169(1): 247-57.

McCarthy J, Turley E, Wilson C, Price M, Bullard K, Beck M, Simpson M. (2005) Hyaluronan biosynthesis in prostate carcinoma growth and metastasis. In Hyaluronan: Structure, Metabolism, Biological activities, Therapeutic Applications; Chapter 4, Hyaluronan and Tumors. Eds E.A. Balasz and V.C. Hascall.

Sommer BJ, Barycki JJ, and Simpson MA. (2004) Characterization of human UDP-glucose dehydrogenase: Cys 276 is required for the second of two successive oxidations. J Biol Chem. 279: 23590-96.

Yang J, Price MA, Wilson C, Ferrone S, Neudauer CL, Xia H, Iida J, Simpson MA, McCarthy JB. (2004) Melanoma chondroitin sulfate proteoglycan enhances focal adhesion kinase and ERK activation by distinct mechanisms. J Cell Biol. 165: 881-91.

Kim HR, Wheeler MA, Wilson CM, Iida J, Eng D, Simpson MA, McCarthy JB and Bullard KM. (2004) Hyaluronan Facilitates Invasion of Colon Carcinoma Cells In Vitro via Interaction with CD44. Cancer Res. 64: 4569-76.

McCarthy JB and Simpson MA. (2003) Hyaluronan in prostate cancer progression. Glycoforum online reviews (invited).

Bullard KM, Kim HR, Wheeler MA, Wilson CM, Neudauer CL, Simpson MA, McCarthy JB. (2003) Hyaluronan synthase-3 is upregulated in metastatic colon carcinoma cells and manipulation of expression alters matrix retention and cellular growth. Int J Cancer 107(5): 739-46.

Simpson MA, Wilson CM, McCarthy JB. (2002) Inhibition of prostate tumor cell hyaluronan synthesis impairs subcutaneous growth and vascularization in immunocompromised mice. Amer J Pathol, 161(3): 849-857.

Simpson MA, Wilson CM, Furcht LT, Spicer AP, Oegema TR, McCarthy JB. (2002) Manipulation of hyaluronan synthase expression in prostate adenocarcinoma cells alters pericellular matrix retention and adhesion to bone marrow endothelial cells. J Biol Chem. 277: 10050-10057.

Simpson MA, Reiland J, Burger SR, Furcht LT, Spicer AP, Oegema TR Jr, McCarthy JB. (2001) Hyaluronan Synthase Elevation in Metastatic Prostate Carcinoma Cells Correlates with Hyaluronan Surface Retention, a Prerequisite for Rapid Adhesion to Bone Marrow Endothelial Cells. J Biol Chem. 276(21): 17949-17957.

Iida J, Pei D, Kang T, Simpson MA, Herlyn M, Furcht LT, McCarthy JB. (2001) Melanoma Chondroitin Sulfate Proteoglycan Regulates Matrix Metalloproteinase-dependent Human Melanoma Invasion into Type I Collagen. J Biol Chem. 276(22): 18786-18794.

Eisenmann KM, McCarthy JB, Simpson MA, Keely PJ, Guan JL, Tachibana K, Lim L, Manser E, Furcht LT, Iida J. (1999) Melanoma Chondroitin Sulphate Proteoglycan Regulates Cell Spreading Through Cdc42, Ack-1 and p130cas. Nature Cell Biol. 1: 507-513.

Simpson MA, LiCata V, Ribarik Coe N, Bernlohr DA. (1999) Biochemical and Biophysical Analysis of the Intracellular Lipid-binding Proteins of Adipocytes. Mol Cell Biochem. 192: 33-40.

Coe NR, Simpson MA, Bernlohr DA. (1999) Targeted Disruption of the Adipocyte Lipid Binding Protein (aP2 protein) Gene Impairs Fat Cell Lipolysis and Increases Cellular Fatty Acid Levels. J Lipid Res. 40: 967-72.

Simpson MA and Bernlohr DA. (1998) Testing of the Portal Hypothesis: Analysis of a Series of Adipocyte Lipid Binding Protein Phenylalanine 57 Mutants. Biochemistry 37: 10980-10986.

Bernlohr DA, Ribarik Coe N, Simpson MA, Hertzel AV. (1997) Regulation of gene expression in adipose cells by polyunsaturated fatty acids. Adv Exp Med Biol. 422: 145-156.

Ory J, Kane CD, Simpson MA, Banaszak LJ and Bernlohr DA. (1997) Biochemical and Crystallographic Analyses of a Portal Mutant of the Adipocyte Lipid-binding Protein. J Biol Chem. 272: 9793-9801.

Bernlohr DA, Simpson MA, Hertzel AV and Banaszak LJ. (1997) Intracellular Lipid-binding Proteins and their Genes. Ann Rev Nutr. 17: 277-303.

Bernlohr DA and Simpson MA. (1996) Adipose tissue and lipid metabolism. In Biochemistry of Lipids, Lipoproteins and Membranes. D.E. Vance and J.E. Vance (Eds.). Elsevier Science BV.

LaLonde JM, Levenson (Simpson) MA, Roe JJ, Bernlohr DA and Banaszak LJ. (1994) Adipocyte Lipid-binding Protein Complexed with Arachidonic Acid: Titration Calorimetry and X-ray Crystallographic Studies. J Biol Chem. 269: 25339-25347.